References
- Berk B C, Alexander R W. Vasoactive effects of growth factors. Biochem Pharmacol 1989; 38: 219–225
- Bhargava G, Rifas L, Makman M H. Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells. J Cell Phvsiol 1979; 100: 365–374
- Carpenter G, Wahl M I. The epidermal growth factor family. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors I and II, M B Sporn, A B Roberts. Springer-Verlag, Berlin 1990; 69–171
- Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990; 265: 7709–7712
- Carter N B, Fawcett A A, Hales J R, Moore G P, Panaretto B A. Circulatory effects of a depilatory dose of mouse epidermal growth factor in sheep. J Physiol Lond 1988; 403: 27–39
- Cilento B G, Freeman M R, Schneck F X, Retik A B, Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 1994; 152: 665–670
- Eika B, Levin R M, Longhurst P A. Comparison of urinary bladder function in rats with hereditary diabetes insipidus, streptozotocin-induced diabetes mellitus, and nondiabetic osmotic diuresis. J Urol 1994; 151: 496–502
- Hollenberg M D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 1994; 15: 108–114
- Hollenberg M D. The acute actions of growth factors in smooth muscle systems. Life Sci 1994; 54: 223–235
- Jørgensen P E, Hilchey S D, Nexø E, Poulsen S S, Quilley C P. Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 1993; 139: 227–234
- Karim O MA, Pienta K, Seki N, Mostwin J L. Stretch-mediated visceral smooth muscle growth in vitro. Am J Physiol 1992; 262: R895–R900
- Malmgren A, Sjögren C, Uvelius B, Mattiasson A, Andersson K-E, Andersson P O. Cystometrical evaluation of bladder instability in rats with infravesical outflow obstruction. J Urol 1987; 137: 1291–1294
- Malmquist U, Arner A, Uvelius B. Contractile and cyto-skeletal proteins in smooth muscle during hypertrophy and its reversal. Am J Physiol 1991; 260: 1085–1093
- Messing E M, Hanson P, Ulrich P, Erturk E. Epidermal growth factor–interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 1987; 138: 1329–1335
- Prigent S A, Lemoine N R. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992; 4: 1–24
- Riden D J, Kirby J D, Maizels M. Expression of transforming growth factor beta and epidermal growth receptor mRNA in UPJ obstruction. Proceedings of the american academy of pediatrics. 1993; 62, abstract
- Shing Y, Christofori G, Hanahan D, et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 1993; 259: 1604–1607
- Takayanagi I. Effects of urogastrone on mechanical activities of the stomach and intestine of guinea-pig. J Pharm Pharmacol 1980; 32: 228–230
- Toyoda H, Komurasaki T, Uchida D, et al. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995; 270: 7495–7500
- Vinter-Jensen L, Juhl C O, Djurhuus J C, et al. Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol 1995; 147: 1330–1338
- Vinter-Jensen L, Smerup M, Jørgensen P E, et al. Chronic treatment in the rat with epidermal growth factor stimulates growth of the urinary tract. Urol Res 1996; 24: 15–21